Onesource Specialty Pharma Ltd.
ONESOURCE
Rank in Stocks
#5948
OneSource Specialty Pharma Limited is a biopharmaceutical company focused on... OneSource Specialty Pharma Limited is a biopharmaceutical company focused on the discovery, advancement, production, and market introduction of biological drug products, primarily offered in diverse injectable formulations. The company conducts its operations internationally, with a footprint in India, Ireland, and the United States. It delivers comprehensive contract development and manufacturing (CDMO) services for biologics, encompassing all phases from preclinical and clinical development to commercial-scale supply. Its offerings extend to integrated drug-device systems such as pre-filled syringes, various pen injectors (including dial, push, and pull-push types for both variable and fixed doses), and autoinjectors. Furthermore, OneSource Specialty Pharma manufactures sterile injectable drugs and soft gelatin capsules, and provides specialized biologics solutions tailored for microbial and mammalian cell-line biopharmaceuticals, as well as for cell, gene, and RNA therapies. Established in 2007, the company, headquartered in Bengaluru, India, was formerly known as Stelis Biopharma Limited until its rebranding in February 2024.
Share Price
$17.22
Last synced: 2026-11-09
Market Cap
$1.97B
Change (1 day)
1.69%
Change (1 year)
-13.07%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Onesource Specialty Pharma Ltd. (ONESOURCE)
Category
Healthcare
EPS for Onesource Specialty Pharma Ltd. (ONESOURCE)
EPS as of September 2026 TTM: $0.00
According to Onesource Specialty Pharma Ltd.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of 0.00, an increase over its 2024 EPS of $-0.41.
EPS history for Onesource Specialty Pharma Ltd. from 2023 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -99.95% |
| 2025 | 0.00 | -99.95% |
| 2024 | $-0.41 | -51.80% |
| 2023 | $-0.85 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -978,850.00% |
US
|
|
| $-7.07 | 441,775.00% |
US
|
|
| $-5.29 | 330,525.00% |
AU
|
|
| $12.88 | -805,106.25% |
BE
|
|
| $21.56 | -1,347,600.00% |
NL
|
Questions about Onesource Specialty Pharma Ltd.'s earnings per share (EPS)
What is Onesource Specialty Pharma Ltd.'s earnings per share (EPS)?
Onesource Specialty Pharma Ltd.'s earnings per share (EPS) over the last twelve months is $0.00, as of Sep 2026.
What was Onesource Specialty Pharma Ltd.'s earnings per share (EPS) in 2025?
In 2025, Onesource Specialty Pharma Ltd.'s earnings per share (EPS) was 0.00, compared with $-0.41 in 2024.
How has Onesource Specialty Pharma Ltd.'s earnings per share (EPS) changed since 2023?
From 2023 to 2025, Onesource Specialty Pharma Ltd.'s earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2023 ($-0.85).
How does Onesource Specialty Pharma Ltd.'s earnings per share (EPS) compare with similar companies?
Onesource Specialty Pharma Ltd.'s earnings per share (EPS) ($0.00) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.